CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

Clinical trials for CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) explained in plain language.

Never miss a new study

Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) trials appear

Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 17 Not yet recruiting 3 Not yet finished but already full! 3 Completed 3 Terminated 1

New hope for patients out of options: experimental drug enters first human trials

Disease control Terminated

This early-stage study tested a new drug called voruciclib, both alone and combined with another drug (venetoclax), in adults with advanced blood cancers like leukemia and lymphoma. The main goal was to find safe dosage levels and see if the treatment showed any early signs of he…

Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

Phase: PHASE1 • Sponsor: MEI Pharma, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) trials appear

New hope for patients out of options: experimental drug enters first human trials